Please click here to access the transaction website in respect of the offer for LiDCO Group plc

Hemodynamic
monitoring at the
heart of recovery

Hemodynamic
monitoring for the
entire patient pathway

new-lidco-unity-logo

non-invasive and
minimally invasive
hemodynamic monitoring

 

Hemodynamic Monitoring for the entire patient pathway

Why choose LiDCO

    Safe

  • Dual finger sensors for non-invasive use.
  • Extensively validated including when used with vasoactive drugs.
  • Calibrated cardiac output values from existing radial and venous catheters.

    Proven

  • Only arterial waveform analysis algorithm unchanged in 15 years.
  • Over 200 clinical studies.
  • Improved patient outcomes.

    Flexible

  • Switch from non-invasive to minimally invasive to calibrated with the same disposable.
  • Hemodynamic management across the whole clinical pathway.
200+
CLINICAL STUDIES
showing improved outcomes

OVER 50%
of NHS hospitals use
LiDCO technology

15%
9%

LiDCO TECHNOLOGY
associated with a mortality reduction from 15% to 9%
IMPLEMENTING
ERAS PROTOCOLS...

has the potential to save
$400KP.A.
5
x
detect blood loss
5 TIMES FASTER
than major competitors
PROVEN TO WORK
in unstable patients

CUTS THE RATE
of postoperative complications
BY 50%
REDUCES
length of stay post surgery
BY 24%
References available on request